Novolog Pharm-Up 1966 Ltd (NVLG) — Cash Flow-to-Debt Ratio
Novolog Pharm-Up 1966 Ltd (NVLG) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of ILA-44.21 Million could theoretically repay 0% of its total liabilities (ILA1.78 Billion) in one year. See Novolog Pharm-Up 1966 Ltd (NVLG) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Novolog Pharm-Up 1966 Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Novolog Pharm-Up 1966 Ltd across 12 annual periods. Also explore NVLG net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Novolog Pharm-Up 1966 Ltd (2014–2025)
Year-by-year debt coverage analysis for Novolog Pharm-Up 1966 Ltd. For market capitalisation and broader financial context, see Novolog Pharm-Up 1966 Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | ILA-16.50 Million | ILA1.78 Billion | ▼ -115.5% |
| 2024 | 0.06x | ILA158.52 Million | ILA2.65 Billion | ▼ -28.6% |
| 2023 | 0.08x | ILA200.01 Million | ILA2.39 Billion | ▲ +24.3% |
| 2022 | 0.07x | ILA132.65 Million | ILA1.97 Billion | ▲ +49.9% |
| 2021 | 0.04x | ILA83.39 Million | ILA1.86 Billion | ▲ +45.1% |
| 2020 | 0.03x | ILA58.48 Million | ILA1.89 Billion | ▼ -42.5% |
| 2019 | 0.05x | ILA101.45 Million | ILA1.89 Billion | ▲ +265.9% |
| 2018 | 0.01x | ILA23.96 Million | ILA1.63 Billion | ▼ -70.7% |
| 2017 | 0.05x | ILA86.37 Million | ILA1.72 Billion | ▲ +259.6% |
| 2016 | 0.01x | ILA20.28 Million | ILA1.45 Billion | ▼ -84.7% |
| 2015 | 0.09x | ILA140.29 Million | ILA1.54 Billion | ▼ -30.0% |
| 2014 | 0.13x | ILA160.59 Million | ILA1.23 Billion | — |